Evolution of the Average Target: Roche Holding AG

Evolution of the Target Price: Roche Holding AG

Changes in Analyst Recommendations: Roche Holding AG

4c9a9e1.5kirWZWVp0czm6YaIoeiik4K910xHn3eHESnixSoRoY.3zj_baD61D144_V-Vevs7hRwhTRQZwWVbyXuvGHRc8uhH_k71ueTcHD6yQ~ff31bec514714758bbd677ee91fe4a52
09-30 Roche Holding AG : Deutsche Bank is Neutral ZD
09-29 Roche Holding AG : Gets a Sell rating from Jefferies ZD
09-29 Roche Holding AG : Deutsche Bank is Neutral ZD
09-29 RBC Notes Roche's Long-term Pipeline Potential After 'Mixed' Pharma Day MT
09-23 Berenberg: Roche's Pharma Day Expected to Highlight Breast Cancer Drugs, Among Others MT
09-23 Roche Holding AG : Receives a Buy rating from RBC ZD
09-23 Roche Holding AG : Berenberg remains Neutral ZD
09-15 Roche Holding AG : Goldman Sachs reiterates its Neutral rating ZD
09-09 RBC Capital Markets Starts Roche Coverage with Outperform Rating MT
09-09 RBC Starts Roche Coverage at Outperform on Base Business Improvement, 'Underappreciated' Pipeline MT
09-09 Roche Holding AG : RBC keeps its Buy rating ZD
09-08 Roche Holding AG : Barclays maintains a Buy rating ZD
08-28 Germany's DAX Index Extends Gains; BioNTech Tumbles After Scrapping Cancer Vaccine Trial MT
08-20 Cancer vaccines finally garner the spotlight Alphavalue
08-10 AlphaValue/Baader Europe Downgrades to Reduce, Lifts PT MT
08-07 Morgan Stanley Upgrades Roche to Overweight, Boosts PT MT
07-27 ROCHE HOLDINGS AG : Bernstein reaffirms its Buy rating ZD
07-24 ROCHE HOLDINGS AG : Deutsche Bank sticks Neutral ZD
07-24 Berenberg Lifts Roche Price Target Amid Upcoming Catalysts MT
07-23 Roche Holding: Good Q2; late-stage pipeline execution key to sustained re-rating Alphavalue
07-23 ROCHE HOLDINGS AG : Bernstein gives a Buy rating ZD
07-23 Swiss stocks - Factors to watch on July 23 RE
07-20 Wall Street's Patience Runs Thin Zonebourse
07-20 Could AI chip boom make ASML Europe's first trillion-dollar firm? RE
07-15 Berenberg Downgrades Qiagen Rating, Price Target Amid Rising Competition, Growth Concerns MT

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+16.27%
+9.08%
+6.1%
+7.94%
+8.57%
+8.12%
+34.02%
-3%
+9.61%
Average +10.75%
Weighted average by Cap. +11.42%


Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
19
Last Close Price
345.70CHF
Average target price
375.34CHF
Spread / Average Target
+8.57%
High Price Target
434.50CHF
Spread / Highest target
+25.69%
Low Price Target
230.00CHF
Spread / Lowest Target
-33.47%

Analyst Consensus Detail

Consensus revision (last 18 months)

Trader
Investor
Global
Quality
ESG MSCI
AA
  1. Stock Market
  2. Stocks
  3. ROP Stock
  4. 0QOK Stock
  5. Consensus Roche Holding AG